Home » Stocks » Cooper Companies

The Cooper Companies, Inc. (COO)

Stock Price: $300.31 USD -6.52 (-2.12%)
Updated Aug 11, 2020 4:03 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 16.02B
Revenue (ttm) 2.54B
Net Income (ttm) 343.10M
Shares Out 53.33M
EPS (ttm) 6.87
PE Ratio 43.71
Forward PE 24.69
Dividend $0.06
Dividend Yield 0.02%

Stock Quote

Trading Day Aug 11, 2020
Last Price $300.31
Previous Close $306.83
Change ($) -6.52
Change (%) -2.12%
Day's Open 308.33
Day's Range 299.18 - 308.57
Day's Volume 320,535
52-Week Range 236.68 - 365.68

More Stats

Market Cap 16.02B
Enterprise Value 18.10B
Earnings Date (est) Sep 3, 2020
Ex-Dividend Date Jul 22, 2020
Shares Outstanding 53.33M
Float 48.77M
EPS (basic) 6.94
EPS (diluted) 6.87
FCF / Share 4.75
Dividend $0.06
Dividend Yield 0.02%
Earnings Yield 2.29%
FCF Yield 1.46%
Payout Ratio 0.90%
Shares Short 860,006
Short Ratio 1.83
Short % of Float 2.06%
Beta 0.88
PE Ratio 43.71
Forward PE 24.69
P/FCF Ratio 68.56
PS Ratio 6.30
PB Ratio 4.42
Revenue 2.54B
Operating Income 428.50M
Net Income 343.10M
Free Cash Flow 233.60M
Net Cash -2.08B
Net Cash / Share -39.07
Gross Margin 69.11%
Operating Margin 16.86%
Profit Margin 13.50%
FCF Margin 9.19%
ROA 4.30%
ROE 9.57%
ROIC 12.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (13)

Buy 6
Overweight 1
Hold 6
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$324.64*
(8.10% upside)
Low
285
Current: $300.31
High
351
Target: 324.64
*Average 12-month price target from 11 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue2,6532,5332,1391,9671,7971,7181,5881,4451,3311,159
Revenue Growth4.76%18.41%8.76%9.44%4.62%8.19%9.87%8.59%14.87%-
Gross Profit1,7571,6321,3661,1731,0701,0921,027924805677
Operating Income547403429324237306341288228162
Net Income467140373274204270296248175113
Shares Outstanding49.4049.1048.9048.5048.5048.0648.6247.9146.9045.53
Earnings Per Share9.332.817.525.594.145.515.965.053.632.43
EPS Growth232.03%-62.63%34.53%35.02%-24.86%-7.55%18.02%39.12%49.38%-
Dividend Per Share0.060.060.060.060.060.060.060.060.060.06
Dividend Growth0%0%0%0%0%0%0%0%0%-
Operating Cash Flow713669594510391455416315336268
Capital Expenditures-292--127-153-243-238-178-99.78-104-73.76
Free Cash Flow421669466357148217238215233194
Cash & Equivalents89.0077.7088.8010116.4325.2277.3912.845.183.57
Total Debt1,8262,0231,1731,3341,3491,382345374380611
Net Cash / Debt-1,737-1,945-1,084-1,233-1,333-1,357-267-361-375-608
Assets6,2756,1134,8594,4794,4604,4583,1372,9412,6252,525
Liabilities2,6462,8051,6831,7831,7861,870714728687858
Book Value3,6283,3083,1762,6962,6682,5702,4052,1931,9371,667
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name The Cooper Companies, Inc.
Country United States
Employees 12,000
CEO Albert George White

Stock Information

Ticker Symbol COO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: COO

Description

The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive option, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in San Ramon, California.